IGC Pharma, Inc. (IGC)
NYSEAMERICAN: IGC · Real-Time Price · USD
0.3066
+0.0052 (1.73%)
Jun 6, 2025, 4:00 PM - Market closed
IGC Pharma Cash Flow Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
| Net Income | -8.81 | -13 | -11.51 | -15.02 | -8.81 | -7.32 | Upgrade
|
| Depreciation & Amortization | 0.63 | 0.64 | 0.66 | 0.65 | 0.48 | 0.15 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.04 | -0.04 | 0.04 | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.09 | 3.45 | - | 0.83 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | 0.05 | 0.17 | 0.78 | Upgrade
|
| Stock-Based Compensation | 1.53 | 1.77 | 2.84 | 2.2 | 0.66 | 0.77 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.09 | 0.09 | 0.13 | 1.72 | - | - | Upgrade
|
| Other Operating Activities | 0.03 | - | - | -0.43 | - | -0.01 | Upgrade
|
| Change in Accounts Receivable | -0.05 | -0.03 | 0.01 | 0.05 | -0.04 | -0.05 | Upgrade
|
| Change in Inventory | 1.12 | 1.01 | 0.9 | 1.93 | -1.23 | -4 | Upgrade
|
| Change in Accounts Payable | 0.19 | 0.24 | -0.45 | 0.5 | -0.29 | 0.44 | Upgrade
|
| Change in Other Net Operating Assets | 0.64 | 0.67 | 0.34 | 0.05 | -1.73 | 0.55 | Upgrade
|
| Operating Cash Flow | -4.59 | -5.2 | -7.05 | -7.46 | -10.8 | -8.68 | Upgrade
|
| Capital Expenditures | -0.11 | -0.14 | -0.31 | -0.24 | -1.47 | -4.39 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.02 | 0.04 | 0.54 | 0.03 | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -0.53 | -0.38 | -0.31 | -0.54 | -0.12 | -0.08 | Upgrade
|
| Investment in Securities | - | 0.15 | -0.15 | - | 4.98 | -5.08 | Upgrade
|
| Investing Cash Flow | -0.62 | -0.32 | -0.24 | -0.74 | 3.39 | -9.55 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 0.53 | - | Upgrade
|
| Total Debt Issued | - | - | - | - | 0.53 | - | Upgrade
|
| Long-Term Debt Repaid | - | -0 | -0 | -0 | - | - | Upgrade
|
| Total Debt Repaid | -0 | -0 | -0 | -0 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -0 | -0 | -0 | -0 | 0.53 | - | Upgrade
|
| Issuance of Common Stock | 4.32 | 3.53 | 0.1 | 4.14 | 14.16 | - | Upgrade
|
| Other Financing Activities | - | - | - | - | - | -0.06 | Upgrade
|
| Financing Cash Flow | 4.31 | 3.52 | 0.1 | 4.14 | 14.69 | -0.06 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.01 | -0.01 | -0.08 | -0.03 | 0.02 | -0.07 | Upgrade
|
| Net Cash Flow | -0.91 | -2 | -7.26 | -4.09 | 7.29 | -18.35 | Upgrade
|
| Free Cash Flow | -4.7 | -5.34 | -7.36 | -7.7 | -12.27 | -13.07 | Upgrade
|
| Free Cash Flow Margin | -380.26% | -396.80% | -807.57% | -1939.04% | -1366.37% | -320.87% | Upgrade
|
| Free Cash Flow Per Share | -0.07 | -0.09 | -0.14 | -0.15 | -0.29 | -0.33 | Upgrade
|
| Cash Interest Paid | - | - | - | - | - | 0.01 | Upgrade
|
| Levered Free Cash Flow | -3.7 | -3.17 | -3.37 | -2.47 | -9.21 | -11.16 | Upgrade
|
| Unlevered Free Cash Flow | -3.7 | -3.17 | -3.37 | -2.47 | -9.21 | -11.16 | Upgrade
|
| Change in Net Working Capital | -0.35 | -1.06 | -0.99 | -4.58 | 3.3 | 3.33 | Upgrade
|
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.